MicroRNA let-7a suppresses the growth and invasion of cholesteatoma keratinocytes

Zhang,Wenjing; Chen,Xiaohua; Qin,Zhaobing

doi:10.3892/mmr.2014.2971

MicroRNA let-7a suppresses the growth and invasion of cholesteatoma keratinocytes

Authors:
- Wenjing Zhang
- Xiaohua Chen
- Zhaobing Qin
View Affiliations

Affiliations: Department of Otology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450003, P.R. China
Published online on: November 18, 2014 https://doi.org/10.3892/mmr.2014.2971
Pages: 2097-2103

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cholesteatomas are benign epidermally‑derived lesions of the temporal bone that are caused by migration of hyperproliferative keratinocytes into the middle ear and mastoid cavity. The molecular mechanisms that regulate the pathogenesis of cholesteatomas are currently not fully understood. The present study demonstrated the antigrowth and anti‑invasive effects of let‑7a microRNA (miRNA) on cholesteatoma keratinocytes. Let‑7a inhibited the growth of cholesteatoma keratinocytes through two different mechanisms: Restriction of the proliferation of keratinocytes by promoting cell cycle arrest in the G0/G1 phase, and the induction of apoptosis of the cells. In addition to its role in the inhibition of cell growth, let‑7a suppressed the migration and invasion of cholesteatoma keratinocytes. A mechanistic study showed that let‑7a downregulated the expression of miR‑21. Considering the function of miR‑21 in the regulation of proliferation and apoptosis, let‑7a may control cell proliferation and apoptosis by regulating miR‑21, and its targets, in cholesteatoma keratinocytes. In conclusion, the present study showed that let‑7a downregulates the expression of miR‑21, resulting in the suppression of proliferation and induction of apoptosis. The results of the present study reveal the crucial role of let‑7a miRNA in the inhibition of growth and invasion of cholesteatoma keratinocytes.

View Figures

View References

1	Louw L: Acquired cholesteatoma: summary of the cascade of molecular events. J Laryngol Otol. 127:542–549. 2013. View Article : Google Scholar : PubMed/NCBI
2	Preciado DA: Biology of cholesteatoma: special considerations in pediatric patients. Int J Pediatr Otorhinolaryngol. 76:319–321. 2012. View Article : Google Scholar : PubMed/NCBI
3	Alves AL, Pereira CS, de Carvalho MF, Fregnani JH and Ribeiro FQ: EGFR expression in acquired middle ear cholesteatoma in children and adults. Eur J Pediatr. 171:307–310. 2012. View Article : Google Scholar
4	Barbara M, Raffa S, Murè C, et al: Keratinocyte growth factor receptor (KGF-R) in cholesteatoma tissue. Acta Otolaryngol. 128:360–364. 2008. View Article : Google Scholar : PubMed/NCBI
5	Jin BJ, Min HJ, Jeong JH, Park CW and Lee SH: Expression of EGFR and microvessel density in middle ear cholesteatoma. Clin Exp Otorhinolaryngol. 4:67–71. 2011. View Article : Google Scholar : PubMed/NCBI
6	Yamamoto-Fukuda T, Takahashi H and Koji T: Expression of keratinocyte growth factor (KGF) and its receptor in a middle-ear cavity problem. Int J Pediatr Otorhinolaryngol. 76:76–81. 2012. View Article : Google Scholar
7	Kuczkowski J, Bakowska A, Pawelczyk T, Narozny W and Mikaszewski B: Cell cycle inhibitory protein p27 in human middle ear cholesteatoma. ORL J Otorhinolaryngol Relat Spec. 68:296–301. 2006. View Article : Google Scholar : PubMed/NCBI
8	Liu W, Ren H, Ren J, et al: The role of EGFR/PI3K/Akt/cyclinD1 signaling pathway in acquired middle ear cholesteatoma. Mediators Inflamm. 2013:6512072013. View Article : Google Scholar : PubMed/NCBI
9	Sakamoto T, Kondo K, Yamasoba T, et al: Overexpression of ErbB-2 protein in human middle ear cholesteatomas. Laryngoscope. 114:1988–1991. 2004. View Article : Google Scholar : PubMed/NCBI
10	Chen X and Qin Z: Post-transcriptional regulation by microrna-21 and let-7a microRNA in paediatric cholesteatoma. J Int Med Res. 39:2110–2118. 2011. View Article : Google Scholar
11	Friedland DR, Eernisse R, Erbe C, Gupta N and Cioffi JA: Cholesteatoma growth and proliferation: posttranscriptional regulation by microRNA-21. Otol Neurotol. 30:998–1005. 2009. View Article : Google Scholar : PubMed/NCBI
12	Djuranovic S, Nahvi A and Green R: A parsimonious model for gene regulation by miRNAs. Science. 331:550–553. 2011. View Article : Google Scholar : PubMed/NCBI
13	Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
14	Akimoto R, Pawankar R, Yagi T and Baba S: Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec. 62:257–265. 2000. View Article : Google Scholar : PubMed/NCBI
15	Bujía J, Kim C, Boyle D, et al: Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma. Laryngoscope. 106:217–220. 1996. View Article : Google Scholar : PubMed/NCBI
16	Bujia J, Kim C, Ostos P, et al: Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity. Eur Arch Otorhinolaryngol. 253:252–255. 1996. View Article : Google Scholar : PubMed/NCBI
17	Kato A, Ohashi Y, Masamoto T, et al: Interleukin-6 and tumour necrosis factor alpha synthesized by cholesteatoma cells affect mucociliary function in the eustachian tube. Acta Otolaryngol. 38(Suppl 5): 90–97. 1998.
18	Mehta D, Daudia A, Birchall JP and Banerjee AR: The localization of matrix metalloproteinases-8 and -13 in cholesteatoma, deep-meatal and post-auricular skin: a comparative analysis. Acta Otolaryngol. 127:138–142. 2007. View Article : Google Scholar : PubMed/NCBI
19	Thornton JE and Gregory RI: How does Lin28 let-7 control development and disease? Trends Cell Biol. 22:474–482. 2012. View Article : Google Scholar : PubMed/NCBI
20	Wong TS, Man OY, Tsang CM, et al: MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. J Cancer Res Clin Oncol. 137:415–422. 2011. View Article : Google Scholar :
21	Childs G, Fazzari M, Kung G, et al: Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol. 174:736–745. 2009. View Article : Google Scholar : PubMed/NCBI
22	Mayr C, Hemann MT and Bartel DP: Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science. 315:1576–1579. 2007. View Article : Google Scholar : PubMed/NCBI
23	Johnson SM, Grosshans H, Shingara J, et al: RAS is regulated by the let-7 microRNA family. Cell. 120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
24	Park SM, Shell S, Radjabi AR, et al: Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle. 6:2585–2590. 2007. View Article : Google Scholar : PubMed/NCBI
25	Frankel LB, Christoffersen NR, Jacobsen A, et al: Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar
26	Zhao H, Dupont J, Yakar S, Karas M and LeRoith D: PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells. Oncogene. 23:786–794. 2004. View Article : Google Scholar : PubMed/NCBI